Dynamic Parameters in Evaluation of Fluid Responsiveness

March 5, 2023 updated by: Martin Balik, Charles University, Czech Republic

Dynamic Parameters in Evaluation of Fluid Resposiveness in Cardiac Surgery Patients in the Early Postoperative Period

Intravenous infusion of fluids in patients after surgery is a very important part of treatment. However, administering too much or too little fluid can lengthen the stay in the intensive care unit or even harm the patient. Therefore, fluid therapy should be tailored to the individual needs of each patient. Several methods are available to assess which patients will likely benefit from fluid administration. However, each of these methods is useful only under certain conditions. The study aims to explore some less-known, yet promising tests which could make adequate fluid administration more precise and easier to achieve.

Study Overview

Detailed Description

Adequate fluid therapy is one of the most important variables influencing patient outcome in intensive care. Fluid therapy should be tailored to the individual needs of each patient. Static parameters of preload have proved to be of little predictive value, therefore dynamic parameters are preferred for prediction of fluid responsiveness. Ideally, the cardiac output increases by 10% after a standardised fluid challenge. There are several methods already available to differentiate fluid-responsive from fluid-unresponsive patients, most notably the passive leg-raise. However, each of these methods has its own set of indications and contraindications. Also, a combination of tests could guide clinician´s decision in cases where the results of a single test are not entirely conclusive. Therefore, it would be desirable to add some less-known methods for prediction of fluid responsiveness, like the end-expiratory and end-inspiratory occlusion tests along with the assessment of diastolic properties of cardiac ventricles.

The aims of the study are:

  • to determine the optimal increase in LVOT VTi to reliably predict fluid responsiveness
  • to explore the accuracy of echocardiographic LVOT VTi evaluation during end-expiratory and end-inspiratory occlusion tests and their combination
  • to assess the difference in echocardiographic properties of cardiac ventricles in fluid-responsive and fluid-unresponsive patients
  • to compare the prediction based on echocardiography with the response to a standardised fluid challenge
  • to assess the feasibility and practicality of echocardiographic monitoring in anesthetised cardiac surgery patients in intensive care

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Prague 2, Czechia, 120 00
        • Dept of Anaesthesia and Intensive Care, General University Hospital, 1st Medical Faculty, Charles University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All patients undergoing elective CABG at the Deparment of Cardiovascular Surgery of the General University Hospital in Prague, who meet all the inclusion criteria and give their informed consent.

Description

Inclusion Criteria:

  • patients after elective coronary artery bypass grafting
  • hypovolemia indicated for volumotherapy by the attending physician based on clinical and laboratory signs (ScvO2 under 65 % with serum lactate above 2 mmol/l, increase of vasopressoric support with CVP under 5 mmHg)
  • intubated and ventilated patients
  • sedation without spontaneous breathing activity
  • no pulmonary pathology on X-ray after surgery
  • normal systolic and diastolic function of both ventricles (left ventricular ejection fraction above 50 %, TAPSE of the right ventricle above 20 mm, FAC of the right ventricle above 30 %)
  • informed consent signed before surgery

Exclusion Criteria:

  • aggresive artificial ventilation (PEEP above 10 cmH2O, Pmax above 30 cm H2O)
  • ARDS, pneumothorax, fluidothorax
  • hemodynamically significant valvular disease
  • atrial fibrillation or other arrhythmia with irregular heartbeat
  • intraabdominal hypertension with pressures above 15 mmHg
  • open thorax
  • bad echogenicity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prediction of fluid responsiveness
Time Frame: The first hour after surgery
fluid responsiveness is defined as a 10 % increase in cardiac output after a standardised fluid challenge; the prediction will be made based on the diastolic properties of both cardiac ventricles and the changes in LVOT VTi during end-expiratory and end-inspiratory occlusion tests
The first hour after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Echocardiographic evaluation of LVOT VTi and its changes
Time Frame: The first hour after surgery
TTE measurement of LVOT VTi and its changes during end-expiratory, end-inspiratory occlusion tests and after a standardised fluid challenge of a colloid
The first hour after surgery
Cardiac output monitoring with Vigileo FloTrac
Time Frame: The first hour after surgery
continous measurement of cardiac output with Vigileo FloTrac and its correlation with the changes of echocardiographic parameters
The first hour after surgery
Arterial pressure response
Time Frame: The first hour after surgery
invasive arterial blood pressure
The first hour after surgery
Heart rate response
Time Frame: The first hour after surgery
heart rate
The first hour after surgery
Oxygenation response
Time Frame: The first hour after surgery
pulse oxymetry
The first hour after surgery
Central venous pressure response
Time Frame: The first hour after surgery
central venous pressure
The first hour after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Michal Porizka, MD, PhD, Dept of Anest and Intensive Care, General University Hospital, Prague

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

December 1, 2020

Study Completion (Actual)

July 1, 2022

Study Registration Dates

First Submitted

January 27, 2020

First Submitted That Met QC Criteria

February 23, 2020

First Posted (Actual)

February 25, 2020

Study Record Updates

Last Update Posted (Estimate)

March 7, 2023

Last Update Submitted That Met QC Criteria

March 5, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on testing functional haemodynamic parameters for preload assessment

Subscribe